NEW YORK, NY / ACCESSWIRE / April 24, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
The investigation concerns whether Baxter and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
[Click here to join a class action]
On April 14, 2017, Baxter disclosed that an employee of the Company had received a grand jury subpoena related to a criminal investigation by the Antitrust Division of the U.S. Department of Justice into the Company's sales practices of intravenous saline.
On this news, Baxter's share price has fallen during intraday trading on April 17, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
SOURCE: Pomerantz LLP
ReleaseID: 460406
